Radiofrequency Ablation of Renal Tumors

Michael J. Stone, Aradhana M. Venkatesan, Julia Locklin, Peter Pinto, Marston Linehan, Bradford J. Wood

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

Radiofrequency ablation (RFA) of renal tumors is a promising technique that plays a unique and increasingly important role in urologic oncology practices. RFA is appealing as a minimally invasive therapy that may be performed on an outpatient basis. It enables treatment of an area 3 to 5 cm in diameter, with relatively low morbidity and mortality rates. Most interventional radiologists (IRs) are familiar with RFA of liver tumors, and several principles and techniques used in the liver may be extrapolated for use in the kidney. However, it is crucial to bear in mind that local tumor ablation in the kidney presents unique challenges, secondary to the kidney's unique anatomic and physiologic features. Clinical and technical considerations, risks, and complications pertaining to RFA of renal tumors are reviewed here, including approaches commonly used in our practice.

Original languageEnglish (US)
Pages (from-to)132-139
Number of pages8
JournalTechniques in vascular and interventional radiology
Volume10
Issue number2
DOIs
StatePublished - Jun 2007
Externally publishedYes

Keywords

  • Von Hippel-Lindau syndrome
  • kidney
  • radiofrequency ablation
  • renal cell carcinoma

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Radiofrequency Ablation of Renal Tumors'. Together they form a unique fingerprint.

Cite this